Manigandan Chandrasekaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Manigandan Chandrasekaran has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Alan Bainbridge
6 shared publications- Nicola J. Robertson
Institute for Women’s Health, University College London, London, UK
6 shared publications Ernest B. Cady
Department of Medical Physics and Bio-engineering, University College London Hospitals NHS Foundation Trust, London WC1E 6DB, UK
4 shared publicationsMariya Hristova
4 shared publicationsStuart Faulkner
Institute for Women’s Health, University College London, London WC1E 6AU, UK
4 shared publications- Xavier Golay
Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK
4 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by Springer Nature in Nature Health
- Vol. 1 (10) , 1082-1091
Combined impact of smoking, alcohol and social inequalities on premature mortality in urban India
Associations with mortality of social inequalities, smoking and drinking differ widely between populations. Here we recruited 500,810 adults aged ≥35 years from Chennai city during 1998–2001 in South India and followed to 2020 for verbal-autopsy-assessed cause-specific mortality. Among those initially without chronic disease, multivariable-adjusted Cox regression (censored at age 70 years) related initial characteristics to mortality rates. Even among non-smoking non-drinkers, those with no schooling had almost three times the mortality rate ratio (RR) of those with >11 years education (men, RR of 2.76, 95% confidence interval (CI) 2.58–2.95; women, RR of 2.93, 95% CI 2.69–3.19), with substantial mortality excesses from each major disease category. These social inequalities were further exacerbated by much higher smoking and drinking prevalences among less educated men. Adjusted for education, male smoking (versus not, RR of 1.26, 95% CI 1.22–1.29) and drinking (versus not, RR of 1.52, 95% CI 1.48–1.56) were independently associated with risk and together almost doubled male mortality (both versus neither, RR of 1.89, 95% CI 1.84–1.94). Few women (<0.1%) smoked or drank.
- 19 June 2026
- Published by Springer Nature in Nature Health
- Vol. 1 (10) , 1082-1091
Open AccessCombined impact of smoking, alcohol and social inequalities on premature mortality in urban India
Associations with mortality of social inequalities, smoking and drinking differ widely between populations. Here we recruited 500,810 adults aged ≥35 years from Chennai city during 1998–2001 in South India and followed to 2020 for verbal-autopsy-assessed cause-specific mortality. Among those initially without chronic disease, multivariable-adjusted Cox regression (censored at age 70 years) related initial characteristics to mortality rates. Even among non-smoking non-drinkers, those with no schooling had almost three times the mortality rate ratio (RR) of those with >11 years education (men, RR of 2.76, 95% confidence interval (CI) 2.58–2.95; women, RR of 2.93, 95% CI 2.69–3.19), with substantial mortality excesses from each major disease category. These social inequalities were further exacerbated by much higher smoking and drinking prevalences among less educated men. Adjusted for education, male smoking (versus not, RR of 1.26, 95% CI 1.22–1.29) and drinking (versus not, RR of 1.52, 95% CI 1.48–1.56) were independently associated with risk and together almost doubled male mortality (both versus neither, RR of 1.89, 95% CI 1.84–1.94). Few women (<0.1%) smoked or drank.
- 30 January 2023
- Published by Wiley in Acta Paediatrica
- Vol. 112 (4) , 635-641
Hypocarbia is associated with adverse outcomes in hypoxic ischaemic encephalopathy (HIE)
Aim: Hypocarbia in the early postnatal period might exacerbate brain injury in babies with hypoxic ischaemic encephalopathy following birth asphyxia. This mini‐review summarised studies on pCO2 values that were monitored periodically in term newborns with moderate/severe hypoxic–ischaemic encephalopathy and correlated with short or long‐term outcomes.Methods: We searched the databases MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), web of science and the Cochrane Library and identified nine studies.Results: Among the nine included studies, therapeutic hypothermia was administered in seven studies. In most studies, blood pCO2 levels were measured from birth till 72 h of life or till the endpoint of therapeutic hypothermia. Eight studies showed that any hypocarbia (moderate or severe, or cumulative) was associated with an increased risk of adverse outcomes in the form of brain injury in MRI, death or neurodevelopmental disability.Conclusion: Hypocarbia could lead to adverse short‐term and long‐term outcomes despite therapeutic hypothermia in neonates with HIE. Hence, it is vital to monitor pCO2 levels closely in these infants and consider strategies to maintain pCO2 levels in the normal range.
- 30 January 2023
- Published by Wiley in Acta Paediatrica
- Vol. 112 (4) , 635-641
Hypocarbia is associated with adverse outcomes in hypoxic ischaemic encephalopathy (HIE)
Aim: Hypocarbia in the early postnatal period might exacerbate brain injury in babies with hypoxic ischaemic encephalopathy following birth asphyxia. This mini‐review summarised studies on pCO2 values that were monitored periodically in term newborns with moderate/severe hypoxic–ischaemic encephalopathy and correlated with short or long‐term outcomes.Methods: We searched the databases MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), web of science and the Cochrane Library and identified nine studies.Results: Among the nine included studies, therapeutic hypothermia was administered in seven studies. In most studies, blood pCO2 levels were measured from birth till 72 h of life or till the endpoint of therapeutic hypothermia. Eight studies showed that any hypocarbia (moderate or severe, or cumulative) was associated with an increased risk of adverse outcomes in the form of brain injury in MRI, death or neurodevelopmental disability.Conclusion: Hypocarbia could lead to adverse short‐term and long‐term outcomes despite therapeutic hypothermia in neonates with HIE. Hence, it is vital to monitor pCO2 levels closely in these infants and consider strategies to maintain pCO2 levels in the normal range.
- 6 October 2022
- Published by Springer Nature in Journal of Perinatology
- Vol. 42 (12) , 1695-1696
Management of cardiovascular dysfunction in neonates with hypoxic ischaemic encephalopathy; a national survey of current practice in the UK
- 6 October 2022
- Published by Springer Nature in Journal of Perinatology
- Vol. 42 (12) , 1695-1696
Management of cardiovascular dysfunction in neonates with hypoxic ischaemic encephalopathy; a national survey of current practice in the UK
- Open Access
- 2 March 2017
- Published by Springer Nature in Journal of Perinatology
- Vol. 37 (6) , 684-689
Predictive value of amplitude-integrated EEG (aEEG) after rescue hypothermic neuroprotection for hypoxic ischemic encephalopathy: a meta-analysis
Amplitude-integrated electroencephalography (aEEG) is a useful bedside tool in predicting the neurodevelopmental outcome after neonatal encephalopathy; however, the prognostic accuracy may be altered by rescue hypothermic neuroprotection. The objective of this study is to examine the prognostic accuracy of aEEG for predicting long-term neurodevelopmental outcomes in term newborn infants undergoing therapeutic hypothermia for neonatal encephalopathy. We examined all studies (Medline, Cumulative Index to Nursing and Allied Health Literature and the Cochrane Library; 2000 to 2014) comparing aEEG (6, 24, 48 or 72 h) in term encephalopathic babies undergoing therapeutic hypothermia, with neurodevelopmental outcome at 1 year or more. We extracted individual patient data from the eligible studies to calculate prognostic indices with exact confidence intervals (CIs). We considered continuous normal voltage as normal aEEG pattern and discontinuous normal voltage, burst suppression, flat trace and persistently low voltage as abnormal, and defined adverse outcome as death or moderate/severe disability at 1 year. We reviewed a total of 70 articles, 17 of which met the inclusion criteria. Eight studies were excluded and 9 studies (N=520) were included in the meta-analysis. The pooled sensitivity and specificity for an abnormal trace at 6 h of age to predict adverse outcome were 96% (95% CI 91 to 98%) and 39% (95% CI 32 to 46%). The diagnostic odds ratio of an abnormal trace was highest at 48 h (66.9 (95% CI 19.7, 227.2)). A persistantly abnormal aEEG at 48 h or more is associated with an adverse neurodevelopmal outcome. The positive prognostic value of 6 h aEEG is poor and good outcome may occur despite abnormal aEEG. Conversely, a normal 6 h aEEG has a good negative predictive value although do not exclude adverse outcomes.
- 2 March 2017
- Published by Springer Nature in Journal of Perinatology
- Vol. 37 (6) , 684-689
Open AccessPredictive value of amplitude-integrated EEG (aEEG) after rescue hypothermic neuroprotection for hypoxic ischemic encephalopathy: a meta-analysis
Amplitude-integrated electroencephalography (aEEG) is a useful bedside tool in predicting the neurodevelopmental outcome after neonatal encephalopathy; however, the prognostic accuracy may be altered by rescue hypothermic neuroprotection. The objective of this study is to examine the prognostic accuracy of aEEG for predicting long-term neurodevelopmental outcomes in term newborn infants undergoing therapeutic hypothermia for neonatal encephalopathy. We examined all studies (Medline, Cumulative Index to Nursing and Allied Health Literature and the Cochrane Library; 2000 to 2014) comparing aEEG (6, 24, 48 or 72 h) in term encephalopathic babies undergoing therapeutic hypothermia, with neurodevelopmental outcome at 1 year or more. We extracted individual patient data from the eligible studies to calculate prognostic indices with exact confidence intervals (CIs). We considered continuous normal voltage as normal aEEG pattern and discontinuous normal voltage, burst suppression, flat trace and persistently low voltage as abnormal, and defined adverse outcome as death or moderate/severe disability at 1 year. We reviewed a total of 70 articles, 17 of which met the inclusion criteria. Eight studies were excluded and 9 studies (N=520) were included in the meta-analysis. The pooled sensitivity and specificity for an abnormal trace at 6 h of age to predict adverse outcome were 96% (95% CI 91 to 98%) and 39% (95% CI 32 to 46%). The diagnostic odds ratio of an abnormal trace was highest at 48 h (66.9 (95% CI 19.7, 227.2)). A persistantly abnormal aEEG at 48 h or more is associated with an adverse neurodevelopmal outcome. The positive prognostic value of 6 h aEEG is poor and good outcome may occur despite abnormal aEEG. Conversely, a normal 6 h aEEG has a good negative predictive value although do not exclude adverse outcomes.
- 1 January 2015
- Published by Wolters Kluwer Health in Stroke
- Vol. 46 (1) , 275-278
Brain Cell Death Is Reduced With Cooling by 3.5°C to 5°C but Increased With Cooling by 8.5°C in a Piglet Asphyxia Model
Background and Purpose—: In infants with moderate to severe neonatal encephalopathy, whole-body cooling at 33°C to 34°C for 72 hours is standard care with a number needed to treat to prevent a adverse outcome of 6 to 7. The precise brain temperature providing optimal neuroprotection is unknown. Methods—: After a quantified global cerebral hypoxic-ischemic insult, 28 piglets aged P P <0.05). Conclusions—: Cooling to 35°C (an absolute drop of 3.5°C as in therapeutic hypothermia protocols) or to 33.5°C provided protection in most brain regions after a cerebral hypoxic-ischemic insult in the newborn piglet. Although the relatively wide therapeutic range of a 3.5°C to 5°C drop in temperature reassured, overcooling (an 8.5°C drop) was clearly detrimental in some brain regions.
- 1 January 2015
- Published by Wolters Kluwer Health in Stroke
- Vol. 46 (1) , 275-278
Brain Cell Death Is Reduced With Cooling by 3.5°C to 5°C but Increased With Cooling by 8.5°C in a Piglet Asphyxia Model
Background and Purpose—: In infants with moderate to severe neonatal encephalopathy, whole-body cooling at 33°C to 34°C for 72 hours is standard care with a number needed to treat to prevent a adverse outcome of 6 to 7. The precise brain temperature providing optimal neuroprotection is unknown. Methods—: After a quantified global cerebral hypoxic-ischemic insult, 28 piglets aged P P <0.05). Conclusions—: Cooling to 35°C (an absolute drop of 3.5°C as in therapeutic hypothermia protocols) or to 33.5°C provided protection in most brain regions after a cerebral hypoxic-ischemic insult in the newborn piglet. Although the relatively wide therapeutic range of a 3.5°C to 5°C drop in temperature reassured, overcooling (an 8.5°C drop) was clearly detrimental in some brain regions.
- 13 March 2014
- Published by BMJ in Archives of Disease in Childhood
- Vol. 99 (4) , 390-392
Question 1: Does the use of ranitidine increase the risk of NEC in preterm infants?
The consultant questioned the risk of necrotising enterocolitis (NEC) with the use of ranitidine.
- 13 March 2014
- Published by BMJ in Archives of Disease in Childhood
- Vol. 99 (4) , 390-392
Question 1: Does the use of ranitidine increase the risk of NEC in preterm infants?
The consultant questioned the risk of necrotising enterocolitis (NEC) with the use of ranitidine.
- 21 June 2013
- Published by Wiley in Acta Paediatrica
- Vol. 102 (8) , e378-e384
Early clinical predictors of a severely abnormal amplitude‐integrated electroencephalogram at 48 hours in cooled neonates
Aim: There is a need to identify infants with hypoxic ischaemic encephalopathy who have a poor outcome despite therapeutic hypothermia. A severely abnormal amplitude‐integrated electroencephalogram at 48 h predicts death or disability. Our aim was to determine whether clinical assessment at age 3–5 h predicts a severely abnormal amplitude‐integrated electroencephalogram at 48 h or death in cooled infants.Methods: Forty‐one cooled infants, ≥36 weeks' gestation, with moderate‐to‐severe hypoxic ischaemic encephalopathy, were prospectively enrolled. Infants who were moribund, had congenital conditions associated with encephalopathy or had severe cardio‐respiratory instability were excluded. The predictive abilities of the Thompson encephalopathy score and individual signs at age 3–5 h were assessed.Results: All infants with a Thompson score ≥16 at 3–5 h had a severely abnormal amplitude‐integrated electroencephalogram at 6 h and an abnormal short‐term outcome. At 48 h, 75% had a severely abnormal aEEG or died vs. 18% with a score <16 (p = 0.004). Multivariate analysis did not find a significant independent association with any of the individual signs.Conclusion: The Thompson score could be useful to identify infants who will have a poor outcome despite cooling. A score ≥16 should be validated as a prespecified variable in prospective studies.
- 21 June 2013
- Published by Wiley in Acta Paediatrica
- Vol. 102 (8) , e378-e384
Early clinical predictors of a severely abnormal amplitude‐integrated electroencephalogram at 48 hours in cooled neonates
Aim: There is a need to identify infants with hypoxic ischaemic encephalopathy who have a poor outcome despite therapeutic hypothermia. A severely abnormal amplitude‐integrated electroencephalogram at 48 h predicts death or disability. Our aim was to determine whether clinical assessment at age 3–5 h predicts a severely abnormal amplitude‐integrated electroencephalogram at 48 h or death in cooled infants.Methods: Forty‐one cooled infants, ≥36 weeks' gestation, with moderate‐to‐severe hypoxic ischaemic encephalopathy, were prospectively enrolled. Infants who were moribund, had congenital conditions associated with encephalopathy or had severe cardio‐respiratory instability were excluded. The predictive abilities of the Thompson encephalopathy score and individual signs at age 3–5 h were assessed.Results: All infants with a Thompson score ≥16 at 3–5 h had a severely abnormal amplitude‐integrated electroencephalogram at 6 h and an abnormal short‐term outcome. At 48 h, 75% had a severely abnormal aEEG or died vs. 18% with a score <16 (p = 0.004). Multivariate analysis did not find a significant independent association with any of the individual signs.Conclusion: The Thompson score could be useful to identify infants who will have a poor outcome despite cooling. A score ≥16 should be validated as a prespecified variable in prospective studies.
- Open Access
- 10 April 2013
- Published by Springer Nature in BMC Pediatrics
- Vol. 13 (1) , 52
Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours
An early clinical score predicting an abnormal amplitude-integrated electroencephalogram (aEEG) or moderate-severe hypoxic ischemic encephalopathy (HIE) may allow rapid triage of infants for therapeutic hypothermia. We aimed to determine if early clinical examination could predict either an abnormal aEEG at age 6 hours or moderate-severe HIE presenting within 72 hours of birth.
- 10 April 2013
- Published by Springer Nature in BMC Pediatrics
- Vol. 13 (1) , 52
Open AccessEarly clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours
An early clinical score predicting an abnormal amplitude-integrated electroencephalogram (aEEG) or moderate-severe hypoxic ischemic encephalopathy (HIE) may allow rapid triage of infants for therapeutic hypothermia. We aimed to determine if early clinical examination could predict either an abnormal aEEG at age 6 hours or moderate-severe HIE presenting within 72 hours of birth.
- Open Access
- 24 November 2012
- Published by Oxford University Press (OUP) in Brain
- Vol. 136 (1) , 90-105
Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model
Despite treatment with therapeutic hypothermia, almost 50% of infants with neonatal encephalopathy still have adverse outcomes. Additional treatments are required to maximize neuroprotection. Melatonin is a naturally occurring hormone involved in physiological processes that also has neuroprotective actions against hypoxic–ischaemic brain injury in animal models. The objective of this study was to assess neuroprotective effects of combining melatonin with therapeutic hypothermia after transient hypoxia–ischaemia in a piglet model of perinatal asphyxia using clinically relevant magnetic resonance spectroscopy biomarkers supported by immunohistochemistry. After a quantified global hypoxic–ischaemic insult, 17 newborn piglets were randomized to the following: (i) therapeutic hypothermia (33.5°C from 2 to 26 h after resuscitation, n = 8) and (ii) therapeutic hypothermia plus intravenous melatonin (5 mg/kg/h over 6 h started at 10 min after resuscitation and repeated at 24 h, n = 9). Cortical white matter and deep grey matter voxel proton and whole brain 31P magnetic resonance spectroscopy were acquired before and during hypoxia–ischaemia, at 24 and 48 h after resuscitation. There was no difference in baseline variables, insult severity or any physiological or biochemical measure, including mean arterial blood pressure and inotrope use during the 48 h after hypoxia–ischaemia. Plasma levels of melatonin were 10 000 times higher in the hypothermia plus melatonin than hypothermia alone group. Melatonin-augmented hypothermia significantly reduced the hypoxic–ischaemic-induced increase in the area under the curve for proton magnetic resonance spectroscopy lactate/N-acetyl aspartate and lactate/total creatine ratios in the deep grey matter. Melatonin-augmented hypothermia increased levels of whole brain 31P magnetic resonance spectroscopy nucleotide triphosphate/exchangeable phosphate pool. Correlating with improved cerebral energy metabolism, TUNEL-positive nuclei were reduced in the hypothermia plus melatonin group compared with hypothermia alone in the thalamus, internal capsule, putamen and caudate, and there was reduced cleaved caspase 3 in the thalamus. Although total numbers of microglia were not decreased in grey or white matter, expression of the prototypical cytotoxic microglial activation marker CD86 was decreased in the cortex at 48 h after hypoxia–ischaemia. The safety and improved neuroprotection with a combination of melatonin with cooling support phase II clinical trials in infants with moderate and severe neonatal encephalopathy.
- 24 November 2012
- Published by Oxford University Press (OUP) in Brain
- Vol. 136 (1) , 90-105
Open AccessMelatonin augments hypothermic neuroprotection in a perinatal asphyxia model
Despite treatment with therapeutic hypothermia, almost 50% of infants with neonatal encephalopathy still have adverse outcomes. Additional treatments are required to maximize neuroprotection. Melatonin is a naturally occurring hormone involved in physiological processes that also has neuroprotective actions against hypoxic–ischaemic brain injury in animal models. The objective of this study was to assess neuroprotective effects of combining melatonin with therapeutic hypothermia after transient hypoxia–ischaemia in a piglet model of perinatal asphyxia using clinically relevant magnetic resonance spectroscopy biomarkers supported by immunohistochemistry. After a quantified global hypoxic–ischaemic insult, 17 newborn piglets were randomized to the following: (i) therapeutic hypothermia (33.5°C from 2 to 26 h after resuscitation, n = 8) and (ii) therapeutic hypothermia plus intravenous melatonin (5 mg/kg/h over 6 h started at 10 min after resuscitation and repeated at 24 h, n = 9). Cortical white matter and deep grey matter voxel proton and whole brain 31P magnetic resonance spectroscopy were acquired before and during hypoxia–ischaemia, at 24 and 48 h after resuscitation. There was no difference in baseline variables, insult severity or any physiological or biochemical measure, including mean arterial blood pressure and inotrope use during the 48 h after hypoxia–ischaemia. Plasma levels of melatonin were 10 000 times higher in the hypothermia plus melatonin than hypothermia alone group. Melatonin-augmented hypothermia significantly reduced the hypoxic–ischaemic-induced increase in the area under the curve for proton magnetic resonance spectroscopy lactate/N-acetyl aspartate and lactate/total creatine ratios in the deep grey matter. Melatonin-augmented hypothermia increased levels of whole brain 31P magnetic resonance spectroscopy nucleotide triphosphate/exchangeable phosphate pool. Correlating with improved cerebral energy metabolism, TUNEL-positive nuclei were reduced in the hypothermia plus melatonin group compared with hypothermia alone in the thalamus, internal capsule, putamen and caudate, and there was reduced cleaved caspase 3 in the thalamus. Although total numbers of microglia were not decreased in grey or white matter, expression of the prototypical cytotoxic microglial activation marker CD86 was decreased in the cortex at 48 h after hypoxia–ischaemia. The safety and improved neuroprotection with a combination of melatonin with cooling support phase II clinical trials in infants with moderate and severe neonatal encephalopathy.
- Open Access
- 22 November 2012
- Published by Wiley in Journal of Neurochemistry
- Vol. 124 (5) , 645-657
Methyl‐isobutyl amiloride reduces brain Lac/NAA, cell death and microglial activation in a perinatal asphyxia model
Na+/H+ exchanger (NHE) blockade attenuates the detrimental consequences of ischaemia and reperfusion in myocardium and brain in adult and neonatal animal studies. Our aim was to use magnetic resonance spectroscopy (MRS) biomarkers and immunohistochemistry to investigate the cerebral effects of the NHE inhibitor, methyl isobutyl amiloride (MIA) given after severe perinatal asphyxia in the piglet. Eighteen male piglets (aged < 24 h) underwent transient global cerebral hypoxia‐ischaemia and were randomized to (i) saline placebo; or (ii) 3 mg/kg intravenous MIA administered 10 min post‐insult and 8 hourly thereafter. Serial phosphorus‐31 (31P) and proton (1H) MRS data were acquired before, during and up to 48 h after hypoxia‐ischaemia and metabolite‐ratio time‐series Area under the Curve (AUC) calculated. At 48 h, histological and immunohistochemical assessments quantified regional tissue injury. MIA decreased thalamic lactate/N‐acetylaspartate and lactate/creatine AUCs (both p < 0.05) compared with placebo. Correlating with improved cerebral energy metabolism, transferase mediated biotinylated d‐UTP nick end‐labelling (TUNEL) positive cell density was reduced in the MIA group in cerebral cortex, thalamus and white matter (all p < 0.05) and caspase 3 immunoreactive cells were reduced in pyriform cortex and caudate nucleus (both p < 0.05). Microglial activation was reduced in pyriform and midtemporal cortex (both p < 0.05). Treatment with MIA starting 10 min after hypoxia‐ischaemia was neuroprotective in this perinatal asphyxia model.
- 22 November 2012
- Published by Wiley in Journal of Neurochemistry
- Vol. 124 (5) , 645-657
Open AccessMethyl‐isobutyl amiloride reduces brain Lac/NAA, cell death and microglial activation in a perinatal asphyxia model
Na+/H+ exchanger (NHE) blockade attenuates the detrimental consequences of ischaemia and reperfusion in myocardium and brain in adult and neonatal animal studies. Our aim was to use magnetic resonance spectroscopy (MRS) biomarkers and immunohistochemistry to investigate the cerebral effects of the NHE inhibitor, methyl isobutyl amiloride (MIA) given after severe perinatal asphyxia in the piglet. Eighteen male piglets (aged < 24 h) underwent transient global cerebral hypoxia‐ischaemia and were randomized to (i) saline placebo; or (ii) 3 mg/kg intravenous MIA administered 10 min post‐insult and 8 hourly thereafter. Serial phosphorus‐31 (31P) and proton (1H) MRS data were acquired before, during and up to 48 h after hypoxia‐ischaemia and metabolite‐ratio time‐series Area under the Curve (AUC) calculated. At 48 h, histological and immunohistochemical assessments quantified regional tissue injury. MIA decreased thalamic lactate/N‐acetylaspartate and lactate/creatine AUCs (both p < 0.05) compared with placebo. Correlating with improved cerebral energy metabolism, transferase mediated biotinylated d‐UTP nick end‐labelling (TUNEL) positive cell density was reduced in the MIA group in cerebral cortex, thalamus and white matter (all p < 0.05) and caspase 3 immunoreactive cells were reduced in pyriform cortex and caudate nucleus (both p < 0.05). Microglial activation was reduced in pyriform and midtemporal cortex (both p < 0.05). Treatment with MIA starting 10 min after hypoxia‐ischaemia was neuroprotective in this perinatal asphyxia model.